W M Kakimoto
Overview
Explore the profile of W M Kakimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montague B, Kakimoto W, Arepally A, Razavi M, Dake M, Hofmann L
Cardiovasc Intervent Radiol
. 2004 Jul;
27(2):158-63.
PMID: 15259812
We attempted to evaluate the in vitro behavior and performance of balloon-expandable endoprosthetic metallic stents subjected to over-expansion (OE). Seventy-two balloon-expandable endoprosthetic stents, representing 22 models from six manufacturers, were...
2.
Nixon D, Donahoe S, Kakimoto W, Samuel R, Metzner K, Gettie A, et al.
Virology
. 1999 Dec;
266(1):203-10.
PMID: 10612675
In this study, we examined the role of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes (CTLs) in macaques immunized with an attenuated strain of simian immunodeficiency virus (SIVmac239Deltanef) in protection...
3.
Jin X, Demoitie M, Donahoe S, Ogg G, Bonhoeffer S, Kakimoto W, et al.
J Infect Dis
. 1999 Dec;
181(1):165-75.
PMID: 10608763
How the cellular immune response copes with diverse antigenic competition is poorly understood. Responses of virus-specific cytotoxic T lymphocytes (CTL) were examined longitudinally in an individual coinfected with human immunodeficiency...
4.
Ortiz G, Nixon D, Trkola A, Binley J, Jin X, Bonhoeffer S, et al.
J Clin Invest
. 1999 Sep;
104(6):R13-8.
PMID: 10491418
Therapeutic intervention with highly active antiretroviral therapy (HAART) can lead to suppression of HIV-1 plasma viremia to undetectable levels for 3 or more years. However, adherence to complex drug regimens...
5.
Kakimoto W, Gettie A, Smith S, Donahoe S, Jin X, Marx P, et al.
Immunol Lett
. 1999 Apr;
66(1-3):135-40.
PMID: 10203046
Most investigators believe that an effective HIV-1 vaccine will have to induce high levels of HIV-1 specific cytotoxic T-cells (CTL). The macaque SIV challenge/protection model system has been used to...